Fund
Samsara Biocapital
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 3
- Lead
- 1
- New entries
- 2
- Follow ons
- 0
- Latest operation
- 8 August 2026
- Sectors
- Biotech
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 08 Aug | United States, Biotech | Series B | 118 M$ | Lead |
| 23 Jun | United States, Biotech | Series B | 73,8 M$ | Participant |
| 28 Apr | Belgium, Biotech | Series A | 125 M$ | Participant |
Co investors 18 funds crossed
- Novo Holdings 2 operations
- Sofinnova Investments 2 operations
- Adage Capital Management 1 operation
- ADAR1 Capital Management 1 operation
- Aisling Capital 1 operation
- Balyasny Asset Management 1 operation
- Catalio Capital Management 1 operation
- Euclidean Capital 1 operation
- Finchley Healthcare Ventures 1 operation
- Forbion 1 operation
- Galapagos 1 operation
- Janus Henderson Investors 1 operation
- Longwood Fund 1 operation
- Luma Group 1 operation
- Mass General Brigham Ventures 1 operation
- Regeneron Ventures 1 operation
- Sanofi Ventures 1 operation
- The Column Group 1 operation
Funds that appeared in the same rounds, in any capacity. Geographies logged: United States, Belgium.